Kyverna Therapeutics (KYTX) Stock Chart & Stock Price History $2.44 +0.23 (+10.54%) As of 02:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kyverna Therapeutics Stock Price Performance The Kyverna Therapeutics (KYTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 81.67%, with a year-to-date return of -34.68%. In the past month, the stock has increased 16.33%, reflecting recent market activity. As of the latest close, Kyverna Therapeutics traded at $2.21 with a market cap of $95.51 million and volume of 510,167 shares. Receive KYTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kyverna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.30%1 Month Performance+16.33%3 Month Performance-12.12%Year-To-Date Performance-34.68%1 Year Performance-81.67% KYTX Stock Chart for Thursday, May, 22, 2025 KYTX Chart by TradingView Kyverna Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$2.39$2.21-7.53%$2.42$2.16510,167 shs$95.51 million05/20/2025$2.07$2.39+15.46%$2.42$2.071.01 million shs$103.29 million05/19/2025$2.32$2.07-10.78%$2.33$2.06341,967 shs$89.46 million05/16/2025$2.18$2.32+6.42%$2.41$2.27647,974 shs$100.27 million05/15/2025$2.15$2.18+1.40%$2.19$2.06377,136 shs$94.22 million05/14/2025$2.32$2.15-7.33%$2.37$2.06301,060 shs$92.92 million05/13/2025$2.21$2.32+4.98%$2.32$2.16351,816 shs$100.27 million05/12/2025$2.11$2.21+4.74%$2.24$2.14221,059 shs$95.51 million05/09/2025$2.14$2.11-1.17%$2.20$2.05138,630 shs$91.19 million05/08/2025$2.02$2.14+5.69%$2.14$1.96118,511 shs$92.27 million Get the Latest News and Ratings for KYTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kyverna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$2.02$2.02$2.08$1.95169,518 shs$87.30 million05/06/2025$2.13$2.02-5.16%$2.16$1.92276,370 shs$87.30 million05/05/2025$2.28$2.13-6.58%$2.28$2.12188,936 shs$92.06 million05/02/2025$2.22$2.28+2.70%$2.37$2.22108,776 shs$98.54 million05/01/2025$2.31$2.22-3.90%$2.38$2.19249,486 shs$95.95 million04/30/2025$2.04$2.31+13.24%$2.32$2.00243,581 shs$99.84 million04/29/2025$2.05$2.04-0.49%$2.13$2.0383,965 shs$88.17 million04/28/2025$2.10$2.05-2.38%$2.13$2.00119,429 shs$88.60 million04/25/2025$2.14$2.10-1.87%$2.22$2.07153,952 shs$90.76 million04/24/2025$2.13$2.14+0.47%$2.19$2.02303,404 shs$92.49 million04/23/2025$2.10$2.13+1.43%$2.23$2.09227,532 shs$92.06 million04/22/2025$1.99$2.10+5.53%$2.12$1.92292,973 shs$90.76 million04/21/2025$1.86$1.99+6.99%$2.05$1.82263,617 shs$86.01 million Related Companies RVNC Stock Price Chart ORGO Stock Price Chart TKNO Stock Price Chart MBX Stock Price Chart ORKA Stock Price Chart CMPS Stock Price Chart AUTL Stock Price Chart CYRX Stock Price Chart CKPT Stock Price Chart SNDL Stock Price Chart Receive KYTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kyverna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KYTX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kyverna Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kyverna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KYTX Stock Free KYTX Stock Alerts